Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1998-2-11
|
pubmed:abstractText |
Our previous study demonstrated that CD9 is expressed on most mature naive T-cells and delivers a potent costimulatory signal that functions independently of CD28. Here, we investigated whether this CD9-mediated signal is different from the CD28-mediated signal in the mode of costimulation and whether both signals function synergistically for T-cell activation. Anti-CD9 or anti-CD28 monoclonal antibody (mAb) increased [3H]TdR incorporation of naive T-cells in the absence of antigen-presenting cells (APC) when coimmobilized with submitogenic doses of anti-CD3 mAb. The levels of costimulation induced by ligation of CD9 and CD28 were comparable. However, the costimulatory effect differed between soluble anti-CD9 and CD28 mAb. A soluble form of anti-CD28 mAb could costimulate anti-CD3-triggered T-cells, whereas soluble anti-CD9 mAb failed to costimulate. Although anti-CD28 costimulated naive T-cells treated with phorbol myristate acetate (PMA) instead of anti-CD3 mAb, a combination of PMA plus anti-CD9 mAb could not induce T-cell activation. The combined costimulation of anti-CD3-triggered T-cells with anti-CD9 and anti-CD28 mAbs resulted in strikingly enhanced [3H]TdR uptake and lymphokine (IL-2 and IFN-gamma) production when compared to those induced by each costimulation. These results suggest that CD9 and CD28 induce T-cell costimulation using different signaling pathways, thereby inducing synergy in T-cell activation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD28,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD9,
http://linkedlifedata.com/resource/pubmed/chemical/Cd9 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-2,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tetradecanoylphorbol Acetate
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0165-2478
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19-23
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9436464-Animals,
pubmed-meshheading:9436464-Antibodies, Monoclonal,
pubmed-meshheading:9436464-Antigens, CD,
pubmed-meshheading:9436464-Antigens, CD28,
pubmed-meshheading:9436464-Antigens, CD3,
pubmed-meshheading:9436464-Antigens, CD9,
pubmed-meshheading:9436464-Interferon-gamma,
pubmed-meshheading:9436464-Interleukin-2,
pubmed-meshheading:9436464-Lymph Nodes,
pubmed-meshheading:9436464-Lymphocyte Activation,
pubmed-meshheading:9436464-Membrane Glycoproteins,
pubmed-meshheading:9436464-Mice,
pubmed-meshheading:9436464-Mice, Inbred C57BL,
pubmed-meshheading:9436464-Signal Transduction,
pubmed-meshheading:9436464-T-Lymphocyte Subsets,
pubmed-meshheading:9436464-T-Lymphocytes,
pubmed-meshheading:9436464-Tetradecanoylphorbol Acetate
|
pubmed:year |
1997
|
pubmed:articleTitle |
Synergy between CD28 and CD9 costimulation for naive T-cell activation.
|
pubmed:affiliation |
Biomedical Research Center, Osaka University Medical School, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|